Ascendis Pharma A/S 20-F for FY2023
Ascendis Pharma A/S (ASND)
20-F
2024-02-07
For: 2023-12-31
View Original
Added on
April 11, 2026
About this 20-F
Ascendis Pharma A/S filed this 20-F on February 7, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 266.72M EUR
- up 421.2% from 51.17M EUR a year earlier
- Net loss
- 481.45M EUR
- compared with a net loss of 583.19M EUR a year earlier
- Diluted EPS
- -8.55 EUR
- compared with -10.40 EUR a year earlier